James Smeeding

James Smeeding

Director/Board Member chez ALLIED CORP.

Consumer Services
Finance
Health Technology

Profil

James Smeeding is the founder of CannaPharmaRx, Inc. which was founded in 2014.
He held the titles of President, EVP-Professional Services & Director from 2015 to 2016.
Mr. Smeeding is also the founder of International Society for Pharmacoeconomics & Outcomes Rsch.
Currently, Mr. Smeeding holds the position of Director & Vice President-Pharmaceuticals at Allied Corp.
(Canada) since 2020.
He is also the Executive Director at National Association of Specialty Pharmacy and Director at National Association of Cannabis Pharmacy.
Mr. Smeeding's former position was as a Director at Golden Dragon Holding Co. Mr. Smeeding received an MBA degree from The University of Texas at Austin in 1989 and an undergraduate degree from State University of New York at Buffalo in 1972.

Postes actifs de James Smeeding

SociétésPosteDébut
ALLIED CORP. Director/Board Member 02/05/2020
National Association of Specialty Pharmacy Director/Board Member -
National Association of Cannabis Pharmacy Director/Board Member -
Tous les postes actifs de James Smeeding

Anciens postes connus de James Smeeding

SociétésPosteFin
CANNAPHARMARX, INC. Founder 06/04/2016
Founder -
Director/Board Member -
Voir l'expérience en détail de James Smeeding

Formation de James Smeeding

The University of Texas at Austin Masters Business Admin
State University of New York at Buffalo Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de James Smeeding

Relations

100 +

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ALLIED CORP.

Health Technology

CANNAPHARMARX, INC.

Process Industries

Entreprise privées4

Finance

Commercial Services

National Association of Specialty Pharmacy

National Association of Cannabis Pharmacy

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. James Smeeding